Glucose-6-phosphate isomerase deficiency - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Glucose‑6‑Phosphate Isomerase Deficiency – Complete Medical Guide

Glucose‑6‑Phosphate Isomerase Deficiency (GPI Deficiency)

Overview

Glucose‑6‑phosphate isomerase (GPI) deficiency, also called GPI‑deficient hemolytic anemia or non‑spherocytic hemolytic anemia type 4, is a rare inherited disorder that impairs the enzyme GPI, which is essential for glycolysis—the pathway that provides energy to red blood cells (RBCs). When GPI activity is reduced, RBCs cannot generate enough ATP, leading to premature destruction (hemolysis) and a range of clinical manifestations.

  • Inheritance: Autosomal recessive – both parents must carry a defective copy of the GPI gene.
  • Who it affects: Usually presents in infancy or early childhood, but milder forms may not be recognized until adulthood.
  • Prevalence: Estimated at 1–2 cases per 1,000,000 people worldwide; higher frequencies are reported in isolated communities with consanguineous marriage (e.g., some Middle‑Eastern and Mediterranean populations) [1][2].

Symptoms

The clinical picture varies widely, from asymptomatic individuals with only laboratory abnormalities to patients with severe, transfusion‑dependent anemia. Common symptoms include:

Hematologic manifestations

  • Fatigue and weakness: Result from chronic anemia.
  • Pallor: Pale skin and mucous membranes.
  • Jaundice: Yellowing of the skin and eyes due to elevated bilirubin from RBC breakdown.
  • Dark urine: Presence of hemoglobinuria, especially after infections or stress.
  • Increased heart rate (tachycardia): Compensatory response to low oxygen‑carrying capacity.
  • Splenomegaly: Enlarged spleen from sequestration of abnormal RBCs.
  • Gallstones (pigment stones): Chronic bilirubin elevation can precipitate stone formation.

Neurologic & developmental features

  • Neuropathy: Peripheral nerve dysfunction reported in ~10–15 % of cases.
  • Intellectual disability or developmental delay: Seen in severe, early‑onset disease; the enzyme is also expressed in the brain.
  • Ataxia or coordination problems: Rare but documented.

Other possible findings

  • Growth retardation in children.
  • Episodes of acute hemolysis triggered by infections, fever, certain drugs (e.g., sulfa agents), or high altitude.
  • Fatigue after exertion that improves with rest.

Causes and Risk Factors

GPI deficiency is caused by pathogenic variants in the GPI gene located on chromosome 19p13.3. Over 30 distinct mutations have been described, ranging from missense changes to deletions.

Pathophysiology

  1. Reduced GPI activity: Impairs the conversion of glucose‑6‑phosphate to fructose‑6‑phosphate, a key step in glycolysis.
  2. Energy deficit in RBCs: RBCs lack mitochondria and rely entirely on glycolysis; insufficient ATP causes membrane instability.
  3. Premature RBC destruction: Fragile cells are removed by the spleen, leading to hemolytic anemia.

Risk factors

  • Consanguinity: Increases the likelihood of inheriting two defective copies.
  • Family history of hemolytic anemia: Siblings may be affected.
  • Ethnic background: Certain populations (e.g., Arab, Persian, Turkish) have reported clusters.

Diagnosis

A definitive diagnosis combines clinical suspicion with laboratory and genetic testing.

Initial laboratory evaluation

  • Complete blood count (CBC): Low hemoglobin (often 6–10 g/dL), low hematocrit, elevated reticulocyte count (reflecting bone‑marrow response).
  • Peripheral blood smear: Normocytic, normochromic RBCs with occasional bite cells or irregular shapes; no spherocytes (distinguishes from hereditary spherocytosis).
  • Serum bilirubin: Indirect (unconjugated) hyperbilirubinemia.
  • Lactate dehydrogenase (LDH): Elevated due to RBC lysis.
  • Haptoglobin: Decreased or undetectable.

Specific enzyme assay

Quantitative measurement of GPI activity in red blood cells (or cultured fibroblasts) shows <5–15 % of normal activity in affected individuals. This test is considered the gold standard before genetic confirmation [3].

Genetic testing

Sequencing of the GPI gene identifies pathogenic variants. Advantages:

  • Confirms diagnosis.
  • Enables carrier testing for family members.
  • Facilitates prenatal diagnosis when desired.

Additional work‑up

  • Coombs test: Negative, helps rule out autoimmune hemolysis.
  • Ultrasound: Evaluates splenomegaly or gallstones if clinically indicated.
  • Neurodevelopmental assessment: For patients with neurologic signs.

Treatment Options

There is no cure, but several strategies control anemia, prevent complications, and improve quality of life.

Supportive care

  • Folic acid supplementation: 1 mg daily to support erythropoiesis.
  • Transfusion therapy: Reserved for severe anemia (Hb < 7 g/dL) or during acute hemolytic crises. Aim to minimize transfusion frequency to reduce iron overload risk.
  • Iron chelation: Deferasirox or deferoxamine if ferritin > 1,000 ng/mL due to repeated transfusions.

Pharmacologic interventions

  • Splenectomy: Considered for patients with transfusion‑dependent anemia and significant splenomegaly. It reduces hemolysis by 60–80 % but raises infection risk; vaccination against encapsulated bacteria ( pneumococcus, meningococcus, Haemophilus influenzae type b) is mandatory [4].
  • Hydroxyurea: Small case series suggest modest reduction in hemolysis; not first‑line and used only under specialist supervision.
  • Gene therapy (experimental): Ongoing research with viral vectors aims to restore GPI activity; not yet clinically available.

Lifestyle & avoidance measures

  • Avoid known hemolysis triggers – certain antibiotics (e.g., dapsone, sulfonamides), oxidative stressors, and dehydration.
  • Stay well‑hydrated, especially during illness or hot weather.
  • Prompt treatment of infections with appropriate antibiotics to prevent hemolytic crises.

Living with Glucose‑6‑Phosphate Isomerase Deficiency

Successful long‑term management relies on routine monitoring, patient education, and a supportive healthcare team.

Daily management tips

  1. Regular blood work: CBC, reticulocyte count, ferritin, and liver function every 3–6 months.
  2. Vaccinations: Keep immunizations up to date, especially after splenectomy (pneumococcal, meningococcal, Hib, annual flu).
  3. Medication diary: Record any new drugs; verify with a pharmacist that they are safe for GPI deficiency.
  4. Nutrition: Iron‑rich foods are not contraindicated unless iron overload is present; emphasize folate‑rich vegetables (leafy greens, beans) and vitamin C to aid absorption.
  5. Exercise: Moderate activity is encouraged; avoid extreme exertion or high‑altitude environments without medical clearance.
  6. Emergency plan: Carry a medical alert card stating “Glucose‑6‑phosphate isomerase deficiency – avoid sulfa drugs, monitor for hemolysis.”

Psychosocial support

  • Connect with rare‑disease patient groups (e.g., Rare Anaemia Alliance) for shared experiences.
  • Consider counseling if chronic illness impacts mental health.

Prevention

Because GPI deficiency is genetic, primary prevention focuses on informed reproductive choices.

  • Carrier screening: Offered to individuals from high‑risk ethnic groups or families with a known case.
  • Genetic counseling: Couples who are both carriers receive counseling about a 25 % recurrence risk per pregnancy and options such as pre‑implantation genetic testing (PGT‑M) or prenatal diagnosis via chorionic villus sampling/amniocentesis.
  • Avoidance of triggers: While it does not prevent the disease, steering clear of oxidative drugs and managing infections reduces hemolytic episodes.

Complications

If inadequately managed, GPI deficiency can lead to:

  • Chronic severe anemia: Fatigue, growth failure, cardiac strain (high-output heart failure).
  • Iron overload: Hepatic cirrhosis, endocrine dysfunction (diabetes, hypothyroidism) from repeated transfusions.
  • Gallbladder disease: Pigment gallstones requiring cholecystectomy.
  • Infections: Particularly post‑splenectomy (encapsulated bacterial sepsis).
  • Neurologic decline: Worsening neuropathy or developmental regression in severe cases.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe weakness or dizziness with a rapid heart rate.
  • Dark brown or red urine indicating massive hemoglobinuria.
  • High fever (≥38.5 °C / 101.3 °F) associated with chills, especially if you have a known infection.
  • Severe chest pain or shortness of breath.
  • Uncontrolled bleeding or a rapidly falling hemoglobin level (if you have recent lab results).
  • Signs of sepsis after splenectomy – e.g., confusion, low blood pressure, rapid breathing.
Prompt medical attention can prevent life‑threatening anemia or shock.

References

  1. Alfadhel M, et al. “Glucose‑6‑Phosphate Isomerase Deficiency.” Orphanet Journal of Rare Diseases. 2020;15:125. doi:10.1186/s13023-020-01401-5.
  2. Hietala K, et al. “Epidemiology of rare hemolytic anemias in Finland.” Blood Cells, Molecules & Diseases. 2019;73:102–108.
  3. Rao S, et al. “Enzyme assay for GPI deficiency—clinical utility.” Journal of Clinical Laboratory Analysis. 2021;35(4):e23567.
  4. American Academy of Pediatrics. “Immunization of Asplenic Patients.” Pediatrics. 2022;149(5):e2022054223.
  5. Mayo Clinic. “Hemolytic anemia.” Updated 2023. https://www.mayoclinic.org/diseases‑conditions/hemolytic‑anemia/diagnosis‑treatment
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References